The chairman and president of a major Japanese dietary supplement maker yesterday announced that they were resigning, as the company probes dozens of deaths potentially linked to products meant to lower cholesterol.
Kobayashi Pharmaceutical Co is at the center of a health scare linked to its over-the-counter tablets containing red yeast rice, which is fermented with a mold culture.
The company’s board yesterday released a damning external report that said the firm had failed to prioritize consumer safety and acted with an “insufficient sense of urgency.”
Photo: AFP
Red yeast rice or “beni koji” has been used in food, alcoholic drinks and folk medicine for centuries around East Asia.
Medical studies say it can improve cholesterol levels, but also warn of a risk of organ damage depending on the ingredient’s chemical makeup.
Akihiro Kobayashi and Kazumasa Kobayashi were leaving their posts as president and chairman respectively, Kobayashi Pharmaceutical said in a statement.
Both men belong to the firm’s founding family.
The company’s new president is Satoshi Yamane, previously head of sustainability policy, the company said.
Akihiro Kobayashi would remain in an executive role to manage compensation-related matters, it added.
The scandal erupted in March when the company, a household name in Japan, recalled three brands of dietary supplements after customers complained of kidney problems.
The company later said that it had detected a potentially toxic acid produced by the mold at one of its factories.
Last month, the company said it was probing a total of 80 deaths possibly connected to its pills, and investigating whether organs other than kidneys were harmed.
At the time the government called Kobayashi Pharmaceutical’s delay in reporting the number of cases under investigation “extremely regrettable.”
The report by a team of external lawyers released yesterday also criticized the firm’s handling of the matter.
It said that in mid-January and early February, the company began to receive reports of kidney problems from doctors.
“Kobayashi Pharmaceutical had never before received multiple reports of serious cases from doctors in such a short period of time,” the report said. “Despite this, the company did not immediately consider disclosure to consumers, acting with an insufficient sense of urgency.”
The company should have recalled the products right away and reported the incident, but it only did so after conducting internal probes, the lawyers said.
PATENTS: MediaTek Inc said it would not comment on ongoing legal cases, but does not expect the legal action by Huawei to affect its business operations Smartphone integrated chips designer MediaTek Inc (聯發科) on Friday said that a lawsuit filed by Chinese smartphone brand Huawei Technologies Co (華為) over alleged patent infringements would have little impact on its operations. In an announcement posted on the Taiwan Stock Exchange, MediaTek said that it would not comment on an ongoing legal case. However, the company said that Huawei’s legal action would have little impact on its operations. MediaTek’s statement came after China-based PRIP Research said on Thursday that Huawei filed a lawsuit with a Chinese district court claiming that MediaTek infringed on its patents. The infringement mentioned in the lawsuit likely involved
Taipei is today suspending work, classes and its US$2.4 trillion stock market as Typhoon Gaemi approaches Taiwan with strong winds and heavy rain. The nation is not conducting securities, currency or fixed income trading, statements from its stock and currency exchanges said. Authorities had yesterday issued a warning that the storm could affect people on land and canceled some ship crossings and domestic flights. Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) expects its local chipmaking fabs to maintain normal production, the company said in an e-mailed statement. The main chipmaker for Apple Inc and Nvidia Corp said it has activated routine typhoon alert
SEMICONDUCTORS: Taiwan is the company’s fastest-growing market due to growing demand for advanced equipment, Advantest Taiwan chairman Alex Wu said Advantest Corp, the world’s largest chip testing equipment supplier, yesterday said that stronger-than-expected demand from Taiwan Semiconductor Manufacturing Co (台積電) has stretched to far longer than the expected six months, driven by a surge in demand for artificial intelligence (AI) and high-performance-computing (HPC) applications. Normally lead times range from three to four months, but as a majority of AI and HPC chips are packaged using advanced packaging technology, chip-on-wafer-on-substrate, it requires a longer and more complex testing process to ensure every semiconductor die works well before being packaged together, Advantest said. As a result, demand for Advantest’s equipment is running high, the
GROWTH: TSMC increased its projected revenue growth for this year to more than 25 percent, citing stronger-than-expected demand for AI devices and smartphones The Taiwan Institute of Economic Research (TIER, 台灣經濟研究院) yesterday raised its forecast for Taiwan’s GDP growth this year from 3.29 percent to 3.85 percent, as exports and private investment recovered faster than it predicted three months ago. The Taipei-based think tank also expects that Taiwan would see a 8.19 percent increase in exports this year, better than the 7.55 percent it projected in April, as US technology giants spent more money on artificial intelligence (AI) infrastructure and development. “There will be more AI servers going forward, but it remains to be seen if the momentum would extend to personal computers, smartphones and